Bing

NEW YORK (TheStreet) -- Shares of Regeneron Pharmaceuticals (REGN - Get Report) were down by 0.83% to $531 in early afternoon trading on Thursday. On Tuesday, analyst firm RBC called Regeneron …
The Street · 8/27/2015
One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is Regeneron Pharmaceuticals, Inc. (REGN). This Biotechnology industry stock has actually seen estimates rise over the past month for the current ...
Yahoo Finance · 23 hours ago
Healthcare stocks declined on Wall Street today, down 1.8%. More broadly, the Dow Jones Industrial Average was down 1.1%, the Nasdaq declined 1.2% and the S&P 500 was down 1.1%. Some of the biggest losers among healthcare stocks include …
Investor Place · 9/1/2015
More from Bing News
[PR Newswire] – TARRYTOWN, N.Y., and PARIS, Sept. 1, 2015 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) and Sanofi today announced that, in a new pooled analysis of heterozygous …
Jutia Group · 9/1/2015
Regeneron Pharmaceuticals (NASDAQ:REGN)‘s stock had its “buy” rating restated by equities researchers at RBC Capital in a research report issued on Monday, Market Beat Ratings reports. A number of other …
Ticker Report · 8/31/2015
There are nine stocks in the Standard & Poor's 500 index, including biotech Regeneron Pharmaceuticals (REGN), health-care data provider Cerner (CERN) and financial rating firm Moody's (MCO), that have bucked the …
USA Today · 9/1/2015
stocks
As we return to our screen for companies with >$10B market cap and EPS CAGRs for 2015-2018 >20%, biopharma names that appear on the list remain Pharmaceuticals, Bristol-Myers Squibb (BMY), Celgene and …
Barron's · 22 hours ago
The below chart shows the historical "days to cover" for REGN at previous short interest release dates: A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could ...
Market News Video · 8/27/2015
Leaders were clearly under pressure ahead of the open. Nearly 3-in-5 IBD 50 stocks traded lower. Worst hit, Regeneron Pharmaceuticals (NASDAQ:REGN) fell nearly 4%. In other markets, the dollar was mixed, up against the yen, down on the euro. Bonds ...
Investors Business Daily · ByAlan R. Elliott · 9/1/2015
Stock Futures
Raymond James assumed coverage on shares of Regeneron Pharmaceuticals (NASDAQ:REGN)in a report published onMonday, The Fly reports. The firm issued an outperform rating on the biopharmaceutical company’s stock. In related news, Director …
wkrb13.com · 9/1/2015

Regeneron

Company
Regeneron Pharmaceuticals, Inc. is a biotechnology company headquartered in Tarrytown, New York. The company was founded in …
Regeneron Pharmaceuticals, Inc. is a biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, it branched out into the study of both cytokine and tyrosine kinase receptors.
Data from: Wikipedia · Freebase